The global probiotic infant formula market size is projected to increase from USD 526.2 million in 2024 to USD 1,281.2 million by 2034. By 2034, global probiotic infant formula sales are set to soar at 5.2% CAGR.
| Attributes | Key Insights |
|---|---|
| Probiotic Infant Formula Market Size (2024E) | USD 526.2 million |
| Market Value (2034F) | USD 1,281.2 million |
| Value-based CAGR (2024 to 2034) | 5.2% |
With the accelerating problems of gut health and digestive disorders among infants, consumption of probiotic infant formulas is rising rapidly. Rising population of working women is set to create new opportunities for leading companies in the market.
High living costs are compelling working women to support their families financially. Hence, they are relying on infant formula to provide a complete nutrition profile for their growing babies.
The infant formula market is further propelled by increasing awareness among today’s consumers about the growing need for extra nutrition. They are also gradually accepting new formulas other than breast milk. Parents are increasingly choosing formulas with fewer artificial ingredients and organic origins, fueling demand for probiotic infant formula in the market.
Top companies are focusing on meeting the parents' needs for convenience, ease of consumption, and taste acceptability by babies for high sales. Government initiatives and improved access to pediatric care have increased parents' awareness of infant nutritional needs and alternatives to breast milk & safe infant food items.
Marketing tactics such as performance marketing through social media bloggers and influencers have elevated awareness about probiotics-infused infant formulas and have helped widen the customer base. According to Future Market Insights (FMI), considering the upward trajectory of digestive disorders and the need for easy & convenient nutrition-dense infant food, the global market is poised for strong growth by 2034.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The global market displayed steady sales growth from 2019 to 2023. Consumer interest in probiotics has surged due to scientific research on their efficacy and safety in infant health. Some infant formula companies are focusing on research activities to discover the effects of probiotic supplementation on allergy prevention, immune function, and digestive health in an infant.
The industry has grown significantly due to increased consumer awareness of gut health and the desire for natural, organic products. Key companies have introduced probiotic-infused formulas targeting specific health benefits using strains such as Bifidobacterium, Lactobacillus. Innovations in formulation and manufacturing technologies, such as microencapsulation, have improved the viability and stability of probiotic strains in infant formula.
By 2034, global probiotic infant formula sales are set to soar at 5.2% CAGR. This is attributed to growing awareness of the product’s health benefits and high disposable income of millennials to spend on indulgent commodities. Manufacturers’ vast investment results in diverse product formats and flavors, boosting sales in the market.
Growing population and birth rates contribute to its extensive consumer base worldwide. The market is further projected to inflate through retail channels such as hypermarkets and online e-commerce platforms, with brands strategically positioning themselves through competitive pricing.
The table below shows the predicted growth rates of the leading countries. The United States, India, and Australia are anticipated to record high CAGRs of 4.5%, 6.2%, and 7.1%, respectively, through 2034.
| Countries | CAGR (2024 to 2034) |
|---|---|
| United States | 4.5% |
| Germany | 3.4% |
| India | 6.2% |
| Australia | 7.1% |
The table below lists the countries with high demand for infant formula according to the analysis of the global industry.
| Countries | Value (2034) |
|---|---|
| United States | USD 260.1 million |
| Germany | USD 146.1 million |
| India | USD 79.4 million |
| Australia | USD 39.7 million |
The United States probiotic infant formula market is experiencing rapid growth due to numerous manufacturers' innovation and development efforts. Leading companies focus on developing high-quality, nutrition-profile products due to market competition and consumer demand for easy, convenient items.
High purchasing power fuels market growth, as consumers spend on indulgent products that save time and promote health. The United States is projected to surge at a CAGR of 4.5% by 2034.
Sales of Australia is set to reach USD 39.7 million, propelling at a CAGR of 7.1% by 2034. The market value is being significantly boosted by rising clean-label, natural, and organic formulations, and consumer awareness of the harmful effects of chemicals in food.
Customers are actively seeking transparency in their purchasing decisions, particularly regarding the source, provenance, and manufacturing process used. Companies that provide detailed product ingredient lists will likely gain more customer trust, fueling the market.
India's sales is increasing rapidly, owing to the country's growing population and birth rates. Increasing number of newborns in India fuels the infant formula market, particularly the probiotic variant, as parents increasingly invest in premium products for their infants' health.
India's market is propelling due to rising demand and regulatory bodies' safety and efficacy standards. India is set to reach USD 79.4 million by 2034.
Parents in Germany are increasingly aware of the importance of probiotics in infant gut health, leading to a surging demand for probiotic formula to support their babies' digestive and immune systems. Consumers increasingly favor natural and organic infant formulas, seeking products free from artificial additives and organic ingredients.
Probiotic formulas are sold in Germany through various retail channels, including supermarkets, pharmacies, online retailers, and specialty stores, with companies surging their reach. Germany is set to reach USD 146.1 million by 2034.
Manufacturers in Japan are investing in research and development to improve probiotic infant formulas through progressions in strains, microencapsulation techniques, and delivery systems to ensure probiotic viability. Japan's probiotic infant formula market is highly competitive, with established and new entrants vying for market share, characterized by product quality, brand reputation, marketing strategies, and distribution channels.
Leading companies and non-government organizations promote probiotic infant formulas through advertising campaigns, educational materials for healthcare professionals, and social media outreach to engage parents. By 2034, Japan is projected to grow at a significant CAGR.
The table section offers detailed insights into key global probiotic infant formula industry segments. The information will help companies maximize profits by investing in popular ingredients and using preferred sales channels.
| Segment | Market Value (2034) |
|---|---|
| Infant (Age) | USD 512.4 million |
| Bifidobacteria (Ingredient) | USD 358.7 million |
| Online Retail (Sales Channel) | USD 230.6 million |
Based on age, the infant segment is projected to reach USD 512.4 million in 2034. While breastfeeding is recommended, several women find it difficult due to low milk supply, work engagements, or health concerns.
Probiotic infant formula offers a reliable alternative, ensuring complete nutrition for the newborn. It also provides flexibility, allowing both parents to share their responsibilities. Moreover, pediatricians are embracing probiotics for infants born through C-section delivery or those exposed to antibiotics during labor.
Based on the sales channel, the online retail segment is set to reach USD 230.6 million by 2034. Online platforms provide convenience and accessibility for busy parents to shop at their convenience.
Parents can choose the best infant formulas from various brands, supported by detailed product descriptions and customer testimonials for informed decision-making. E-commerce channels often run discounts, promotions, or deals to attract customers as price-conscious parents appreciate cost savings.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Leading companies are investing more in research and development for taste enhancement, improvised texture, and improved health benefits to generate high sales. Enfamil, Envivo, Nestlé Health Science, Nestlé Good Start, Bellamy's Organic, HiPP, Custom Probiotics Inc., and SFI Health are the key companies in the market.
Due to growing consumer demand for probiotic infant formulas, leading manufacturers are strategizing to provide their products at competitive pricing to gain an edge over competitors. They are engaging in collaborations and partnerships to better position themselves in the market to inflate their geographical presence and visibility.
For instance
The market is set to reach USD 526.2 million in 2024.
Demand for probiotic infant formula is slated to rise at a 5.2% CAGR by 2034.
The market is set to reach USD 1,281.2 million in 2034.
Enfamil, Envivo, and Nestlé Health Science are the key players.
Bifidobacteria segment is estimated to hold a significant market share in 2024.
| Market Size (2024) | USD 3,104.8 million |
|---|---|
| Market Value (2034) | USD 6,685.7 million |
| Market Projected Growth Rate (2024 to 2034) | 8% CAGR |
| Market Size (2024) | USD 2,574.1 million |
|---|---|
| Market Value (2034) | USD 5,093.1 million |
| Market Growth Rate (2024 to 2034) | 7.1% CAGR |
| Market Size (2024E) | USD 50,126 million |
|---|---|
| Market Value (2034F) | USD 1,15,326 million |
| Value-based CAGR (2024 to 2034) | 8.7% |
| Market Size Value in 2023 | USD 42,645.0 million |
|---|---|
| Market Forecast Value in 2033 | USD 78,818.9 million |
| Global Growth Rate (2023 to 2033) | 6.3% CAGR |
Explore Food Supplement and Nutrition Insights
View Reports
Probiotic Infant Formula Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
